Board Opinions
At the May 14, 2013 meeting, the Board stated that Tennessee
Board of Pharmacy Rule 1140-04-.10 is interpreted to allow pharmacists
in an institutional setting to return and use medication that is
either in unit-dose packaging or unopened commercially prepackaged
containers and, “. . . in the professional judgment of the pharmacist
in charge or designee, the medications or related materials meet all
federal and state board standards for product integrity. . .” Review
the following link for the rule in its entirety: www.state.tn.us/sos/
rules/1140/1140-04.pdf.
At the same meeting, Tennessee Board of Pharmacy Rule 1140-
03-.08 in regard to a pharmacy repackaging another pharmacy’s
medications was discussed. The Board concluded that it is currently
a violation for one pharmacy to repackage another pharmacy’s
medications. The Board agreed that the process would be positive
for patient safety, but a rule change is needed to legalize this type
of activity.
quoted from Tennessee Board of Pharmacy June 2013 Newsletter
1 comment:
Compounding products intended for topical, oral or rectal administration and compounding sterile products intended to be administered via injectable routes are two entirely different things and need to be treated as such. There is a definite need for professional certification by Boards of Pharmacy for any individual intending to compound sterile injectable products. This certificatioon should only be issued after the individual can prove by both oral and written testing they are qualified to be granted licensure to practice in the enviroment of sterile products. The necessary equipment and procedures should at all times meet all standards set forth in the UPS and NF and should be randomly checked every six months to ensure compliance.
The entire process should actually be in the hands of qualified manuacturers. Part of the blame here falls on the physicians shoulders also as they are apparently requesting products not available commerically, or, the CFO's and Administrators of the institutions want to use the cheapest products, not necessarily the safest. No matter, whether it be pharmacist, physicians, administrators, or who ever the bottome line is MONEY and greed put over patient safety.
Post a Comment